🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

PH94B

Vista Gen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines for anxiety, depression, and other CNS disorders. Their CNS pipeline includes PH94B and PH10, rapid-onset neuroactive nasal sprays for anxiety and depression, respectively.

Tags: AV-101, CNS disorders, PH10, PH94B, anxiety treatment, biopharmaceutical, depression treatment

Symbol: VTGN

Recent Price: $2.81

Industry: Biotechnology

CEO: Mr. Shawn K. Singh J.D.

Sector: Healthcare

Employees: 41

Address: 343 Allerton Avenue, South San Francisco, CA 94080

Phone: 650 577 3600

Leadership

  • Ann Cunningham, MBA, Director
  • Joanne Curley, Ph.D., Director
  • Maggie FitzPatrick, Chair of the Board
  • Jerry Gin, Ph.D., MBA, Director
  • Mary L. Rotunno, J.D., Director
  • Jon S. Saxe, J.D., LL.M, Director
  • Shawn K. Singh, J.D., Chief Executive Officer and Director

Last updated: 2024-12-31